Study for treatment of leukemia in older adults
Primary disease category: Cancer
Secondary disease categories: Leukemia & Lymphoma
Sponsor: Southwest Oncology Group
Protocol number: E2906
Projected enrollment dates: January 2014 to September 2019
Official study title: Phase III Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults
External link(s):
UA Cancer Center Website
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT02085408